Exploring 6-F-DET. To explore a different substance…

IUPAC name:
ID: 5101 · Formula: C14H19FN2 · Molecular weight: 234.312
InChI: InChI=1S/C14H19FN2/c1-3-17(4-2)8-7-11-10-16-14-9-12(15)5-6-13(11)14/h5-6,9-10,16H,3-4,7-8H2,1-2H3
InChI Key: RPWUTEXLVPDNEA-UHFFFAOYSA-NThis stereoisomerAny stereoisomer

Szara, S. DMT (N,N-dimethyltryptamine) and homologues: Clinical and pharmacological considerations. In Psychotomimetic Drugs; Efron, DH, Ed., Raven Press, New York, 1970; pp 275–286. 1.9 MB.

Faillace, LA; Vourlekis, A; Szara, S. Clinical evaluation of some hallucinogenic tryptamine derivatives. J. Nerv. Ment. Dis., 1 Jan 1967, 145 (4), 306–313. 635 kB.

Blair, JB; Kurrasch-Orbaugh, D; Marona-Lewicka, D; Cumbay, MG; Watts, VJ; Barker, EL; Nichols, DE. Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. J. Med. Chem., 1 Jan 2000, 43 (24), 4701–4710. 494 kB. https://doi.org/10.1021/jm000339w

Blair, JB. Synthesis and pharmacological evaluation of fluorinated hallucinogenic tryptamine analogs and thienopyrrole bioisosteres of N,N-dimethyltryptamine. Ph. D. Thesis, Purdue University, West Lafayette, IN, 1 Jan 1997. 3.3 MB.

Kalir, A; Szara, S. Synthesis and pharmacological activity of fluorinated tryptamine derivatives. J. Med. Chem., 1 Nov 1963, 6 (6), 716–719. 533 kB. https://doi.org/10.1021/jm00342a019

25 May 2018 · Creative Commons BY-NC-SA ·